Agex Therapeutics Stock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agex therapeutics stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agex Therapeutics Stock Today - Breaking & Trending Today

AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock

AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United States , Exchange Commission , Exchange Agreement , Agex Therapeutics Inc , Corporation Law , Preferred Stock , Seriesb Preferred Stock , Delaware General Corporation Law , Private Securities Litigation Reform Act , Agex Therapeutics , Annual Report , Preferred Series , Agex Therapeutics Stock ,

AgeX Therapeutics Reports First Quarter 2023 Financial Results

AgeX Therapeutics Reports First Quarter 2023 Financial Results
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United States , Serina Therapeutics Inc , Agex Therapeutics Inc , Exchange Commission , Juvenescence Limited , Secured Note Line , Restated Secured Convertible Promissory Note , Secured Note , Total Revenues , Accounting Standards Update , Financial Statements Going Concern , Private Securities Litigation Reform Act , Agex Therapeutics , Annual Report , Agex Therapeutics Stock ,

AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results

AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United States , Lifemap Sciences , Lifemap Sciences Inc , Agex Therapeutics Inc , Paycheck Protection Program , National Institutes Of Health , Exchange Commission , Juvenescence Limited , National Institutes , Accounting Standards Update , Financial Statements Going Concern , Annual Report , Private Securities Litigation Reform Act , Agex Therapeutics , Ended December , Secured Note , Agex Therapeutics Stock ,

AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

25.11.2022 - AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on November 22, 2022 it received notification from the staff of the NYSE American (the . ....

United States , Exchange Commission , Agex Therapeutics Inc , About Agex , Tissue Regeneration , Private Securities Litigation Reform Act , Agex Therapeutics , Annual Report , Quarterly Report , Agex Therapeutics Stock ,

AgeX Therapeutics Reports Second Quarter 2022 Financial Results

12.08.2022 - AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended June 30, 2022. Liquidity and Capital Resources . ....

United States , Paycheck Protection Program Loan , Lifemap Sciences Inc , Chardan Capital , Juvenescence Limited , Agex Therapeutics Inc , Lifemap Sciences , Convertible Facility Agreement , Secured Convertible Promissory Note , Secured Note , Sales Agreement , Accounting Standards Update , Financial Statements Going Concern , Quarterly Report , Tissue Regeneration , Private Securities Litigation Reform Act , Agex Therapeutics , Annual Report , Exchange Commissions , Agex Therapeutics Stock ,